Embodiments of the present disclosure provide for methods of using labeled probes, methods of diagnosing Parkinsons disease and related biological events, methods of using labeled probes for monitoring and/or assessing Parkinsons disease treatment, methods of using labeled probes for diagnosing, monitoring, and/or assessing diseases with aberrant melanin-expression, and the like.